1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6C4D1D060210DB4B500258B1D0047B7EF
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/global-medical-affairs-resourcing-benchmark-for-med-communications-content-development-functions?opendocument
18
19opendocument
2034.239.151.124
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services » » Medical Affairs » Medical Communication

Global Medical Affairs Resourcing Benchmark for Med Communications & Content Development Functions

ID: POP-381


Features:

11 Info Graphics

13 Data Graphics

340+ Metrics

6 Narratives


Pages: 31


Published: 2024


Delivery Format: Shipped


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
As organizations strive to disseminate crucial information while adhering to stringent regulations and cost constraints, streamlining resource allocation for Medical Communications and Medical Content Development groups has emerged as a strategic imperative.

By striking the right balance between insourcing and outsourcing decisions, companies can enhance core competencies, streamline costs, and elevate stakeholder engagement across therapeutic domains.

Best Practices, LLC undertook this benchmarking research to probe the resourcing details and capabilities of Med Communications and Medical Content Development functions by assessing the productivity, outsourcing benchmarks, spend, and staffing at mid-sized and large biopharma organizations. This report will equip leadership in Medical Communications & Content Development with strategic acumen to navigate complexities adeptly, boost productivity, and foster sustainable growth.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Consumer Products; Health Care; Clinical Research; Laboratories


Companies Profiled:
AbbVie; Acadia Pharmaceuticals; Agenus; Alexion Pharmaceuticals; Astellas; Dompé; Fidia Pharma USA Inc.; Gilead Sciences; Novartis; Novo Nordisk; Organon; Pfizer; Pixacore; Protagonist Therapeutics; Regeneron; Sanofi; Sobi; Teva Pharmaceuticals; United Therapeutics; UCB Pharma

Study Snapshot

This report offers tailored benchmarks and insights focused on the Medical Communications / Content Development function. The data from this research is drawn by engaging 22 Medical leaders from 20 leading mid-cap and large biopharma organizations, with expertise encompassing HEOR, Medical Publications & Strategy. Medical Communications / Content Development insights are meticulously distilled to ensure relevance and applicability within the scope of this research.

Key topics covered in this report include:

  • Medical Communications / Content Development Outsourcing Trends
  • Scope of Support
  • Productivity and Outsourced Capabilities
  • Staffing Level in Medical Communications / Content Development
  • Benefits of Hybrid Resourcing

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

  • Outsourcing Levels: High levels of outsourcing across all Pubs and Content Development activities are the norm for large and mid-sized biopharma alike.
  • Drivers of Insourcing: Where insourcing is prominent in certain operational areas, key drivers include: Faster initiation of projects, in-house expertise, and cost efficiency.
Table of Contents

Sr. No.
Topic
Slide No.
I.
Executive SummaryPg. 3-8
II.
Medical Publications & Content Resourcing: Scope of Support, Productivity & Capabilities Different ModelsPg. 9-17
III.
Staffing & Resourcing TrendsPg. 18-25
IV.
Profiles of “Hybrid” Resourcers of Med Pubs / ContentPg. 26-30
V.
About Best Practices, LLCPg. 31

    List of Charts & Exhibits

    I. Executive Summary

    • Research methodology and scope overview
    • Benchmark study partners
    • Overarching findings for resourcing and service delivery in Med Communications & Content Development
    • Industry benchmarks for the Med Communications & Content Development function
    • Study summary for Medical Publications & Content Development leadership resourcing decisions

    II. Medical Publications & Content Resourcing: Scope of Support, Productivity & Capabilities Different Models

    • Publications / Content Development team – Scope of support
    • Approximate spend used by Publications / Content Development teams to provide support
    • Annual volume of Pubs / Content Development execution across benchmark organizations
    • Extent of outsourcing in Medical Publications & Content Development
    • Outsourcing x Productivity Matrix: Publication writing
    • Outsourcing x Productivity Matrix: MSL slide deck writing
    • Outsourcing x Productivity Matrix: Medical content development and design of Medical Affairs booths
    • Outsourcing x Productivity Matrix: Other medical content writing

    III. Staffing & Resourcing Trends

    • Staffing levels for each role
    • Brand-specific staffing for each role
    • Benefits of an outsourced medical writing model
    • Use of hybrid models
    • Top lessons learned relating to the outsourcing and insourcing of Pubs / Content Development capabilities
    • Geographical responsibility of benchmarked Publications / Content Development groups

    IV. Profiles of “Hybrid” Resourcers of Med Pubs / Content

    • Outsourcing model effectiveness at mid-cap and small biopharma organizations
    • Hybrid outsourcing profiles
    • Outsourcing model effectiveness at large and mid-cap biopharma organizations
    • Outsourcing model effectiveness at a mid-to-large biopharma firm